JP2018512428A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018512428A5 JP2018512428A5 JP2017552911A JP2017552911A JP2018512428A5 JP 2018512428 A5 JP2018512428 A5 JP 2018512428A5 JP 2017552911 A JP2017552911 A JP 2017552911A JP 2017552911 A JP2017552911 A JP 2017552911A JP 2018512428 A5 JP2018512428 A5 JP 2018512428A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- item
- composition
- compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562144300P | 2015-04-07 | 2015-04-07 | |
| US62/144,300 | 2015-04-07 | ||
| US201562220406P | 2015-09-18 | 2015-09-18 | |
| US62/220,406 | 2015-09-18 | ||
| US201662279382P | 2016-01-15 | 2016-01-15 | |
| US62/279,382 | 2016-01-15 | ||
| PCT/US2016/026498 WO2016164619A2 (en) | 2015-04-07 | 2016-04-07 | Compositions and methods for the treatment of hbv infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018512428A JP2018512428A (ja) | 2018-05-17 |
| JP2018512428A5 true JP2018512428A5 (enExample) | 2019-05-16 |
Family
ID=57072854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017552911A Withdrawn JP2018512428A (ja) | 2015-04-07 | 2016-04-07 | Ｈｂｖ感染の処置のための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20180110796A1 (enExample) |
| EP (1) | EP3280422A4 (enExample) |
| JP (1) | JP2018512428A (enExample) |
| KR (1) | KR20170132327A (enExample) |
| CN (1) | CN107635566A (enExample) |
| AU (1) | AU2016244828A1 (enExample) |
| CA (1) | CA2982125A1 (enExample) |
| HK (1) | HK1250480A1 (enExample) |
| TW (1) | TW201709912A (enExample) |
| WO (1) | WO2016164619A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190290673A1 (en) * | 2016-10-24 | 2019-09-26 | Spring Bank Pharmaceuticals, Inc. | Compositions and methods for the treatment of hbv infection |
| KR101899773B1 (ko) * | 2017-03-07 | 2018-09-18 | 일동제약(주) | 베시포비르 디피복실 또는 이의 약제학적 허용되는 염 함유 과립, 상기 과립을 포함하는 약제학적 조성물 및 이의 제조 방법 |
| WO2020040327A1 (ko) * | 2018-08-23 | 2020-02-27 | 광주과학기술원 | 시클로피록스의 hbv 코어조립 저해 용도 |
| US11166976B2 (en) | 2018-11-08 | 2021-11-09 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| WO2021016543A1 (en) * | 2019-07-25 | 2021-01-28 | Romark Laboratories L.C. | Antiviral combinations of thiazolide compounds |
| CA3155068A1 (en) * | 2019-09-29 | 2021-04-01 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Drug combination containing tlr7 agonist |
| JP2022550454A (ja) * | 2019-10-02 | 2022-12-01 | ユニバーシティ オブ ワシントン | Ｂ型肝炎ウイルス感染の治療のための組成物及び方法 |
| EP4134098A4 (en) | 2020-04-10 | 2024-05-15 | ONO Pharmaceutical Co., Ltd. | Method of cancer therapy |
| KR102292147B1 (ko) * | 2020-11-18 | 2021-08-23 | 주식회사 차백신연구소 | 경구용 항바이러스제 및 리포펩타이드와 폴리(i:c) 아쥬반트를 포함한 치료백신을 유효성분으로 포함하는 만성 b형 간염의 예방 또는 치료용 약제학적 조성물, 약제학적 병용제제, 병용제 키트 |
| US20240108691A1 (en) * | 2020-11-30 | 2024-04-04 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis e virus infection with interferon lambda |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2913889A (en) * | 1987-11-16 | 1989-06-14 | Fox Chase Cancer Center | Determination of anti-pol as an early marker of viral hepatitis infection |
| US6432966B2 (en) * | 1999-10-29 | 2002-08-13 | Smithkline Beecham Corporation | Antiviral combinations |
| KR20080059679A (ko) * | 2000-03-29 | 2008-06-30 | 조지타운 유니버시티 | 델타형 간염 바이러스 감염의 치료방법 |
| US7202354B2 (en) * | 2001-03-30 | 2007-04-10 | Abbott Laboratories | Hepatitis B virus surface antigen mutant and methods of detection thereof |
| US7485312B2 (en) * | 2003-06-20 | 2009-02-03 | Dade Behring Marburg Gmbh | Surface protein (HBsAg) variant of the hepatitis B virus |
| CN101278938A (zh) * | 2008-03-20 | 2008-10-08 | 黑龙江加州国际投资咨询有限公司 | 泰诺福韦酯和恩替卡韦的复方制剂及其抗乙肝病毒的应用 |
| CN102123716B (zh) * | 2008-04-03 | 2013-09-18 | 春堤公司 | 用于治疗病毒感染的化合物和方法 |
| CN107973833A (zh) * | 2010-08-30 | 2018-05-01 | 斯普林银行医药公司 | 作为治疗剂的寡核苷酸类似物的设计 |
-
2016
- 2016-04-07 CA CA2982125A patent/CA2982125A1/en not_active Abandoned
- 2016-04-07 CN CN201680033034.8A patent/CN107635566A/zh active Pending
- 2016-04-07 TW TW105111010A patent/TW201709912A/zh unknown
- 2016-04-07 EP EP16777303.5A patent/EP3280422A4/en not_active Withdrawn
- 2016-04-07 AU AU2016244828A patent/AU2016244828A1/en not_active Abandoned
- 2016-04-07 US US15/565,046 patent/US20180110796A1/en not_active Abandoned
- 2016-04-07 JP JP2017552911A patent/JP2018512428A/ja not_active Withdrawn
- 2016-04-07 HK HK18109890.2A patent/HK1250480A1/zh unknown
- 2016-04-07 KR KR1020177031848A patent/KR20170132327A/ko not_active Withdrawn
- 2016-04-07 WO PCT/US2016/026498 patent/WO2016164619A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018512428A5 (enExample) | ||
| Liang et al. | Present and future therapies of hepatitis B: from discovery to cure | |
| US20250215031A1 (en) | Crystalline forms of tenofovir alafenamide | |
| US20170313707A1 (en) | Solid forms of a toll-like receptor modulator | |
| Qaqish et al. | Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection | |
| WO2018087345A1 (en) | COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON | |
| EP3715349B1 (en) | Bisdiazabicyclo compound for use in treating and/or preventing hepatitis b | |
| KR20180058828A (ko) | Hbv 캡시드 조립 억제제와 인터페론의 조합 치료 | |
| JP2018531272A6 (ja) | Ｈｂｖキャプシドアセンブリ阻害剤とインターフェロンの併用療法 | |
| CA3175236C (en) | COMBINED TREATMENT OF HBV AND HDV INFECTION | |
| US20180110796A1 (en) | Compositions and methods for the treatment of hbv infection | |
| US20230044958A1 (en) | Method of treating virus infection using a tlr7 agonist | |
| JP2019505553A (ja) | インターフェロンラムダによるデルタ型肝炎ウイルス感染の処置 | |
| US20190290673A1 (en) | Compositions and methods for the treatment of hbv infection | |
| KR20120125253A (ko) | Ｂ형 간염 바이러스 감염 치료용 조성물 및 치료방법 | |
| Aguilar-Rubido et al. | Chronic Hepatitis B therapies: challenges and opportunities | |
| Chen et al. | Patents and development of HBV and HCV clinical treatment: From 2001 to April 2005 | |
| Korkmaz et al. | Comparison of adefovir dipivoxil and pegylated interferon alpha-2a treatment in chronic hepatitis B patients | |
| HK40083480A (en) | Combination therapy of hbv and hdv infection | |
| Aguilar-Rubido et al. | Terapias contra la hepatitis B crónica: desafíos y oportunidades | |
| WO2008104133A1 (es) | Terapia combinada para el tratamiento de la hepatitis b crónica | |
| Lieveld et al. | New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review |